BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help
Search Results
Documents 1-2 out of 2 found
  Current Search:  asacol: 2     
HTML
100%
Assessing the Safety/Efficacy of Asacol Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis
Alabama, Arizona, California, Florida, Illinois, Kentucky, Maine, Massachusetts, Assessing the Safety/Efficacy of Asacol Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis.
SmartBrief:  Jan 20 2010 2:11AM
Matching: asacol 		Find similar documents
HTML
100%
Actionable Call Alert : Salix Pharmaceuticals (NASDAQ:SLXP): Top Pick For 2010 - Piper
Piper Jaffray is out with a major call on Salix Pharmaceuticals (NASDAQ:SLXP) this morning calling the stock their Top Small Cap Pick for 2010 and raising target to $58 (prev.

$29).

The firm believes that Street estimates (including their own) have been...

I Stock Analyst:  Jan 10 2010 10:49AM
Matching: asacol 		Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.